Shopping Cart 0
Cart Subtotal
USD 0

China Resources Pharmaceutical Group Ltd (3320) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise chemical medicines, TCMs, biologics, and health food and traditional Chinese medicine, and nutritional products. CR Pharma offers products in forms of oral solid dosage, large infusion bags, powder vials, oral liquid dosage, injections, and topical preparations. The company markets its products through logistics, wholesale, retail and supply chain services in different provinces across China. CR Pharma is headquartered in Hong Kong.

China Resources Pharmaceutical Group Ltd (3320)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 11

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deal Details 15

Partnerships 15

China Resources Pharmaceutical Enters into Agreement with Fujifilm 15

China Resources Pharmaceutical Enters into Co-Development Agreement with WuXi AppTec 16

Pfizer and CR Saike Pharma Enter into Distribution Agreement 17

China Resources Zizhu Pharma Enters into Distribution Agreement with Uni-Bio Science 18

China Resources Zizhu Enters into Agreement with Uni-Bio Science 19

China Resources Pharma and National Center for Nanoscience and Technology Enter into Agreement 20

China Resources Sanjiu Medical To Form Joint Venture 21

Lantheus Medical Imaging Enters Into Co-Marketing Agreement With Beijing Double-Crane Pharma For Ultrasound Contrast Agent 22

Licensing Agreements 23

China Resources Pharma Enters into Licensing Agreement with Xbrane Biopharma 23

China Resources Pharma to Enter into Licensing Agreement with Xbrane Biopharma 24

Basilea Pharma Enters into Licensing Agreement with Shenzhen Gosun Pharma 25

Equity Offering 26

China Resources Pharma Raises USD1.8 Million in IPO 26

Debt Offering 28

China Resources Double Crane Pharma to Raise USD217.8 Million in Public Offering of Bonds 28

Acquisition 29

China Resources Double-Crane Pharma Acquires Hainan Zhonghua Union Pharma 29

China Resources Pharma Acquires 20% Stake in Hefei Tianmai Biotechnology 30

China Resources Sanjiu Medical Acquires Kunming Shenghuo Pharmaceutical 31

China Resources Sanjiu Medical Acquires China Shenghuo Pharma for USD282 Million 32

China Resources Double-Crane Pharma to Acquire 60% Stake in Jinan-based Pharmaceutical Company 33

China Resources Double Crane Pharma Acquires China Resources Saike Pharma for USD578.6 Million 34

The Special Committee Of China Shenghuo Pharma Approves Going Private Proposal From Lan's Int'l Medicine Investment 35

China Resources Sanjiu Medical Acquires 97.18% Stake In Guilin Tianhe Pharma For USD 94 Million 36

Beijing Pharma Rumored To Acquire 42% Stake In Beijing Zizhu Pharma For USD 245 Million 37

Beijing Industrial Development And Beijing Zizhu To Sell 24% Stake In China Pharma For USD 2 Million 38

China Resources Sanjiu Medical To Acquire Guangdong Shunfeng Pharma For USD 95 Million 39

China Resources Pharmaceutical Group Ltd-Key Competitors 40

China Resources Pharmaceutical Group Ltd-Key Employees 41

China Resources Pharmaceutical Group Ltd-Locations And Subsidiaries 42

Head Office 42

Other Locations & Subsidiaries 42

Recent Developments 44

Financial Announcements 44

Mar 21, 2018: China Resources Pharmaceutical Group: Annual Results Announcement For The Year Ended 31 December 2017 44

Aug 24, 2017: China Resources Pharmaceutical Group: Interim Results Announcement For The Six Months Ended 30 June 2017 53

Corporate Communications 57

May 21, 2018: China Resources Pharmaceutical: Change Of Non-Executive Directors And Member Of The Audit Committee 57

Aug 07, 2017: China Resources Pharmaceutical: Appointment of Independent Non-executive Director 58

Appendix 59

Methodology 59

About GlobalData 59

Contact Us 59

Disclaimer 59


List Of Figure

List of Figures

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 11


List Of Table

List of Tables

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

China Resources Pharmaceutical Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 9

China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 11

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

China Resources Pharmaceutical Enters into Agreement with Fujifilm 15

China Resources Pharmaceutical Enters into Co-Development Agreement with WuXi AppTec 16

Pfizer and CR Saike Pharma Enter into Distribution Agreement 17

China Resources Zizhu Pharma Enters into Distribution Agreement with Uni-Bio Science 18

China Resources Zizhu Enters into Agreement with Uni-Bio Science 19

China Resources Pharma and National Center for Nanoscience and Technology Enter into Agreement 20

China Resources Sanjiu Medical To Form Joint Venture 21

Lantheus Medical Imaging Enters Into Co-Marketing Agreement With Beijing Double-Crane Pharma For Ultrasound Contrast Agent 22

China Resources Pharma Enters into Licensing Agreement with Xbrane Biopharma 23

China Resources Pharma to Enter into Licensing Agreement with Xbrane Biopharma 24

Basilea Pharma Enters into Licensing Agreement with Shenzhen Gosun Pharma 25

China Resources Pharma Raises USD1.8 Million in IPO 26

China Resources Double Crane Pharma to Raise USD217.8 Million in Public Offering of Bonds 28

China Resources Double-Crane Pharma Acquires Hainan Zhonghua Union Pharma 29

China Resources Pharma Acquires 20% Stake in Hefei Tianmai Biotechnology 30

China Resources Sanjiu Medical Acquires Kunming Shenghuo Pharmaceutical 31

China Resources Sanjiu Medical Acquires China Shenghuo Pharma for USD282 Million 32

China Resources Double-Crane Pharma to Acquire 60% Stake in Jinan-based Pharmaceutical Company 33

China Resources Double Crane Pharma Acquires China Resources Saike Pharma for USD578.6 Million 34

The Special Committee Of China Shenghuo Pharma Approves Going Private Proposal From Lan's Int'l Medicine Investment 35

China Resources Sanjiu Medical Acquires 97.18% Stake In Guilin Tianhe Pharma For USD 94 Million 36

Beijing Pharma Rumored To Acquire 42% Stake In Beijing Zizhu Pharma For USD 245 Million 37

Beijing Industrial Development And Beijing Zizhu To Sell 24% Stake In China Pharma For USD 2 Million 38

China Resources Sanjiu Medical To Acquire Guangdong Shunfeng Pharma For USD 95 Million 39

China Resources Pharmaceutical Group Ltd, Key Competitors 40

China Resources Pharmaceutical Group Ltd, Key Employees 41

China Resources Pharmaceutical Group Ltd, Other Locations 42

China Resources Pharmaceutical Group Ltd, Subsidiaries 42

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

China Resources Pharmaceutical Group Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise chemical medicines, TCMs, biologics, and health food and traditional Chinese medicine, and nutritional products. CR Pharma offers products in forms of oral solid dosage, large infusion bags, powder vials, oral liquid dosage, injections, and topical preparations. The company markets its products through logistics, wholesale, retail and supply chain services in different provinces across China. CR Pharma is headquartered in Hong Kong.

China Resources Pharmaceutical Group Ltd (3320)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 11

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deal Details 15

Partnerships 15

China Resources Pharmaceutical Enters into Agreement with Fujifilm 15

China Resources Pharmaceutical Enters into Co-Development Agreement with WuXi AppTec 16

Pfizer and CR Saike Pharma Enter into Distribution Agreement 17

China Resources Zizhu Pharma Enters into Distribution Agreement with Uni-Bio Science 18

China Resources Zizhu Enters into Agreement with Uni-Bio Science 19

China Resources Pharma and National Center for Nanoscience and Technology Enter into Agreement 20

China Resources Sanjiu Medical To Form Joint Venture 21

Lantheus Medical Imaging Enters Into Co-Marketing Agreement With Beijing Double-Crane Pharma For Ultrasound Contrast Agent 22

Licensing Agreements 23

China Resources Pharma Enters into Licensing Agreement with Xbrane Biopharma 23

China Resources Pharma to Enter into Licensing Agreement with Xbrane Biopharma 24

Basilea Pharma Enters into Licensing Agreement with Shenzhen Gosun Pharma 25

Equity Offering 26

China Resources Pharma Raises USD1.8 Million in IPO 26

Debt Offering 28

China Resources Double Crane Pharma to Raise USD217.8 Million in Public Offering of Bonds 28

Acquisition 29

China Resources Double-Crane Pharma Acquires Hainan Zhonghua Union Pharma 29

China Resources Pharma Acquires 20% Stake in Hefei Tianmai Biotechnology 30

China Resources Sanjiu Medical Acquires Kunming Shenghuo Pharmaceutical 31

China Resources Sanjiu Medical Acquires China Shenghuo Pharma for USD282 Million 32

China Resources Double-Crane Pharma to Acquire 60% Stake in Jinan-based Pharmaceutical Company 33

China Resources Double Crane Pharma Acquires China Resources Saike Pharma for USD578.6 Million 34

The Special Committee Of China Shenghuo Pharma Approves Going Private Proposal From Lan's Int'l Medicine Investment 35

China Resources Sanjiu Medical Acquires 97.18% Stake In Guilin Tianhe Pharma For USD 94 Million 36

Beijing Pharma Rumored To Acquire 42% Stake In Beijing Zizhu Pharma For USD 245 Million 37

Beijing Industrial Development And Beijing Zizhu To Sell 24% Stake In China Pharma For USD 2 Million 38

China Resources Sanjiu Medical To Acquire Guangdong Shunfeng Pharma For USD 95 Million 39

China Resources Pharmaceutical Group Ltd-Key Competitors 40

China Resources Pharmaceutical Group Ltd-Key Employees 41

China Resources Pharmaceutical Group Ltd-Locations And Subsidiaries 42

Head Office 42

Other Locations & Subsidiaries 42

Recent Developments 44

Financial Announcements 44

Mar 21, 2018: China Resources Pharmaceutical Group: Annual Results Announcement For The Year Ended 31 December 2017 44

Aug 24, 2017: China Resources Pharmaceutical Group: Interim Results Announcement For The Six Months Ended 30 June 2017 53

Corporate Communications 57

May 21, 2018: China Resources Pharmaceutical: Change Of Non-Executive Directors And Member Of The Audit Committee 57

Aug 07, 2017: China Resources Pharmaceutical: Appointment of Independent Non-executive Director 58

Appendix 59

Methodology 59

About GlobalData 59

Contact Us 59

Disclaimer 59


List Of Figure

List of Figures

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 11


List Of Table

List of Tables

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

China Resources Pharmaceutical Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 9

China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 11

China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

China Resources Pharmaceutical Enters into Agreement with Fujifilm 15

China Resources Pharmaceutical Enters into Co-Development Agreement with WuXi AppTec 16

Pfizer and CR Saike Pharma Enter into Distribution Agreement 17

China Resources Zizhu Pharma Enters into Distribution Agreement with Uni-Bio Science 18

China Resources Zizhu Enters into Agreement with Uni-Bio Science 19

China Resources Pharma and National Center for Nanoscience and Technology Enter into Agreement 20

China Resources Sanjiu Medical To Form Joint Venture 21

Lantheus Medical Imaging Enters Into Co-Marketing Agreement With Beijing Double-Crane Pharma For Ultrasound Contrast Agent 22

China Resources Pharma Enters into Licensing Agreement with Xbrane Biopharma 23

China Resources Pharma to Enter into Licensing Agreement with Xbrane Biopharma 24

Basilea Pharma Enters into Licensing Agreement with Shenzhen Gosun Pharma 25

China Resources Pharma Raises USD1.8 Million in IPO 26

China Resources Double Crane Pharma to Raise USD217.8 Million in Public Offering of Bonds 28

China Resources Double-Crane Pharma Acquires Hainan Zhonghua Union Pharma 29

China Resources Pharma Acquires 20% Stake in Hefei Tianmai Biotechnology 30

China Resources Sanjiu Medical Acquires Kunming Shenghuo Pharmaceutical 31

China Resources Sanjiu Medical Acquires China Shenghuo Pharma for USD282 Million 32

China Resources Double-Crane Pharma to Acquire 60% Stake in Jinan-based Pharmaceutical Company 33

China Resources Double Crane Pharma Acquires China Resources Saike Pharma for USD578.6 Million 34

The Special Committee Of China Shenghuo Pharma Approves Going Private Proposal From Lan's Int'l Medicine Investment 35

China Resources Sanjiu Medical Acquires 97.18% Stake In Guilin Tianhe Pharma For USD 94 Million 36

Beijing Pharma Rumored To Acquire 42% Stake In Beijing Zizhu Pharma For USD 245 Million 37

Beijing Industrial Development And Beijing Zizhu To Sell 24% Stake In China Pharma For USD 2 Million 38

China Resources Sanjiu Medical To Acquire Guangdong Shunfeng Pharma For USD 95 Million 39

China Resources Pharmaceutical Group Ltd, Key Competitors 40

China Resources Pharmaceutical Group Ltd, Key Employees 41

China Resources Pharmaceutical Group Ltd, Other Locations 42

China Resources Pharmaceutical Group Ltd, Subsidiaries 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

China Resources Pharmaceutical Group Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.